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Available online 12 May 2016Mitochondrial dysfunction is an early feature of neurodegeneration. We have shown there are mitochondrial
haemoglobin changes with age and neurodegeneration. We hypothesised that altered physiological processes
are associated with recruitment and localisation of haemoglobin to these organelles.
To conﬁrm a dynamic localisation of haemoglobin we exposed Drosophila melanogaster to cyclical hypoxia with
recovery. With a single cycle of hypoxia and recovery we found a relative accumulation of haemoglobin in the
mitochondria comparedwith the cytosol. An additional cycle of hypoxia and recovery led to a signiﬁcant increase
of mitochondrial haemoglobin (p b 0.05). We quantiﬁed ratios of human mitochondrial haemoglobin in 30
Parkinson's and matched control human post-mortem brains. Relative mitochondrial/cytosolic quantities of
haemoglobin were obtained for the cortical region, substantia nigra and cerebellum. In age matched post-
mortem brain mitochondrial haemoglobin ratios change, decreasing with disease duration in female cerebellum
samples (n = 7). The change is less discernible in male cerebellum (n = 18). In cerebellar mitochondria,
haemoglobin localisation in males with long disease duration shifts from the intermembrane space to the
outer membrane of the organelle.
These new data illustrate dynamic localisation of mitochondrial haemoglobin within the cell. Mitochondrial
haemoglobin should be considered in the context of gender differences characterised in Parkinson's disease. It
has been postulated that cerebellar circuitry may be activated to play a protective role in individuals with
Parkinson's. The changing localisation of intracellular haemoglobin in response to hypoxia presents a novel path-
way to delineate the role of the cerebellum in Parkinson's disease.
© 2016 The Authors. Elsevier B.V. andMitochondria Research Society. This is an open access article under the CC
BY license (http://creativecommons.org/licenses/by/4.0/).Keywords:
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Parkinson's disease is most frequently a sporadic occurrence with
themajor risk factor being advanced age. Although a collection of symp-
toms deﬁne this disease, cardinal features correspond to a movement
disorder including a resting tremor, rigidity and difﬁculties with gait
and balance. Despite substantial efforts, the cause of idiopathic
Parkinson's disease still remains unknown and treatment offers only
symptomatic relief over a limited period of time. In recent years
Parkinson's disease research has centred increasingly around the mito-
chondrial organelle. Mitochondrial dysfunction is a feature of
Parkinson's diseasewithmany aspects of this organelle having been im-
plicated in disease generation and progression (Chu, 1802). Parkinson's
disease is associated with mutations of the protein alpha-synucleinse strain 5j; PM, post mortem;
bovine serum albumin; TBS-T,
IV; HSP90, heat shock protein
DH dehydrogenase ubiquinone
Chakrabarti).
ondria Research Society. This is an opwhich is also found accumulated in Lewy bodies – the pathological hall-
mark of this disease (Spillantini et al., 1997). Recently it has been sug-
gested that mitochondrial haemoglobin in neurons is reduced by an
interaction with alpha-synuclein, providing further evidence that mito-
chondrial haemoglobin is important when thinking about Parkinson's
disease (Yang et al., 2016). Altered haemoglobin levels affect the ex-
pression of genes involved in mitochondrial function, demonstrating a
link between mitochondria and haemoglobin (Chuang et al., 2012).
Hypoxia, due to reduced blood perfusion, is linked to ageing
(Daulatzai, 2013). This is particularly relevant to brain ageing and neu-
rodegeneration, as the brain is most sensitive to reduced oxygen levels.
Hypoxia affectsmitochondrial structure and function aswell as intracel-
lular haemoglobin expression (Gleixner et al., 2012). Haemoglobin
(HBA2) expression changes are now also implicated in preclinical
prion disease, and Hbb has been found to interact with subunits of
ATP synthase in a study of Multiple Sclerosis (Xerxa et al., 2016;
Brown et al., 2016).
Our work on the process of neurodegeneration has revealed mito-
chondrial dysfunction as an early event (Chakrabarti et al., 2010). We
want to know how the mitochondrial milieu is adjusted during the pe-
riod of early neural decline when symptoms are just becomingen access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
Table 1
Parkinson's disease and matched control brain samples information. Post mortem interval (PMI) is stated in hours after death. Alpha – synuclein scoring by Parkinson's Brain Bank is in-
cludedwhere available (not applicableNA, for control brains) the alpha-synuclein data for these tissues are visualised in Supplementary Fig. 5. PD1 is early onset cases before age of 60, PD2
is early disease with onset after 60 years, PD3 long disease duration onset after 60 available for this individual and the particular brain region, red boxes indicate the sample was not in-
cluded. All tissues were obtained from Human Tissue Authority approved, Nottingham Health Science Biobank (Nottingham University Hospitals NHS Trust) and Parkinson's UK Brain
Bank (Imperial College London).
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Fig. 1. A. Mitochondrial HbA migrates from the intermembrane space to the outer
membrane in affected human male cerebellum. Mitochondrial samples were sub-
fractioned to allow examination of HbA localisation within the organelle, a
representative gel is shown for each gender and control (total n = 8). The male
Parkinson's disease brain demonstrated a shift in HbA localisation from the
intermembrane space to the outer membrane fraction. This was not seen in the control
or female Parkinson's brain mitochondria. Levels of HbA in the IMS were quantiﬁed in
control and PD samples for both male and female patients (n = 2 for each), using Image
J. Please see Supplemental Fig. 7 for all gel images. Levels of HbA in the IMS were
signiﬁcantly decreased in male PD compared with male control (p = 0.028 using
unpaired two-tailed t-test). No signiﬁcant change in female PD compared with female
control (p $_amp_$gt; 0.05, unpaired two-tailed t-test). Mito fr – mitochondrial fraction,
OM – outer membrane, IMS – inter membrane space, IM – inner membrane, M - matrix.
B. Cycles of hypoxia result in increased hb in Drosophila mitochondrial fractions. Mito-
chondrial/cytoplasmic Hb levels determined using Western blotting, normalised to beta-
actin. Hypoxia conditions: 2.5% O2 30min 25 °C followed by normoxia 30min 25 °C (mid-
dle bar) 2.5% O2 30min 25 °C followed by normoxia 30min 25 °C× 2 (right handbar). 40–
100 ﬂies per condition. n = 3, * p $_amp_$lt; 0.05 (1 tailed t-test).
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neurodegeneration, the pcd5j mouse, and examined its mitochondrial
proteome (Chakrabarti et al., 2006). The pcd5jmouse undergoes a spon-
taneous degenerative process just after weaning. In fact, within 30 days
of weaning, the cerebellum of this strain is nearly devoid of Purkinje
Cells. The degeneration is cell speciﬁc and autonomous and is associated
with an increase in mitophagy in presymptomatic cerebellum. We
showed that there are differences in the mitochondrial proteome in
the pcdmousewhen compared to controls. One of the proteinswe iden-
tiﬁed as changed is haemoglobin. We demonstrated that mitochondrial
haemoglobin levels change in post-mortem Parkinson's disease brain
(Shephard et al., 2013).
The identiﬁcation of haemoglobin in mammalian cells, other than
erythrocytes, was initially ascribed to blood contamination. However,
it has been demonstrated that haemoglobin is detectable in neurons
in vitro after the accepted lifespan of cultured erythrocytes has expired
(Carlson et al., 2008). A growing body of evidence now demonstrates
that haemoglobin is present in a range of cell types, in many of these
cases the effect of intracellular haemoglobin is postulated to be protec-
tive. It has been shown prior to our work that hypoxia upregulates
haemoglobin in alveolar epithelial cell lines (Grek et al., 2011). α- and
β-haemoglobin (HbA and HbB respectively) respond to H2O2 induced
oxidative stress by increasing their levels in HEK293 and hepatic cell
lines (Liu et al., 2011). Haemoglobin mRNA and protein have been de-
tected in rat, mouse and human brain (Biagioli et al., 2009). Our
localisation of haemoglobin to the mitochondrial compartment has
now been conﬁrmed as a protective mechanism in circulating leuko-
cytes (Shephard et al., 2013; Brunyanszki et al., 2015). In neurons eryth-
ropoietin induction has now been shown to increase mitochondrial
function with increasing intraneuronal haemoglobin, in this case a re-
versal of memory impairment is recorded (Horng et al., 2015). A study
of the mitochondrial proteome in Multiple Sclerosis cortex also ﬁnds
beta haemoglobin expression is altered in this neurodegenerative dis-
ease (Biagioli et al., 2009).
Some studies already correlate haemoglobin levels with Parkinson's
disease, simultaneously commenting upon the brain iron accumulation
in Parkinson's and other neurodegenerations (Abbott et al., 2012; Savica
et al., 2009). Since the majority of iron in the body is haemoglobin de-
rived there may be also some connection with observations that
serum and brain iron levels change in Parkinson's disease (Pichler
et al., 2013). Potential interactions between haemoglobin and neurode-
generation are supported by the association of a functional polymor-
phism in the haemoglobin binding protein haptoglobin which
inﬂuences susceptibility to idiopathic Parkinson's disease (Costa-
Mallen et al., 2008). Much of the ﬂuctuation in haemoglobin levels
could be attributed to observed, yet unexplained anaemia in older indi-
viduals (Gaskell et al., 2008).
This study set out to understand localisation of haemoglobin to mi-
tochondria and examine the levels of mitochondrial haemoglobin in
Parkinson's disease post-mortem brains. We want to understand
whether levels of mitochondrial haemoglobin change in Parkinson's
disease compared with controls. We chose to examine mitochondrial
haemoglobin levels in the substantia nigra - as the region of the brain
where neuronal loss is most evident. We sampled cerebellar mitochon-
dria for motor coordination related changes and also the cortex since it
is least frequently associated with Parkinsonism.
2. Materials and methods
2.1. Human tissues
Human brain sections and frozen brain sampleswere obtained from,
Human Tissue Authority approved, NottinghamHealth Science Biobank
(Nottingham University Hospitals NHS Trust) and Parkinson's UK Brain
Bank (Imperial College London). The tissue banks granted us use of the
tissue as end users. The Parkinson's tissue bank has approval from theResearch Ethics Committee for Wales ref. 08/MRE09/31+5. The tissue
collection and procedures at the Nottingham University Hospitals
Biobank have been ethically approved by the Greater Manchester Na-
tional Research Ethics Service. This studywas granted speciﬁc ethics ap-
proval by both of the ethics committees serving the biobanks and also
by the local ethics committee at the School of Veterinary Medicine
and Science at the University of Nottingham. Tissues from human cere-
bellum, cortex and substantia nigra were used for mitochondrial isola-
tions and were frozen at the time of post mortem (PM). Material used
for immunohistochemistry was ﬁxed in PFA at the time of PM. PM
delay varied from a minimum of 2 h after death to a maximum of
6 days. Diagnoses of Parkinson's disease were conﬁrmed at PM. Age at
death varied from 58 to 87 years for Parkinson's disease brains, non-
degenerative human control brains were age matched to within three
years of Parkinson's disease samples, see Table 1. Early cases of
Parkinson's are selected Braak 3 or 4, late cases are all Braak 5 and 6.
Young onset cases are also Braak 5 or 6. Braak stagingwasperformed ac-
cording to published classiﬁcation (Alafuzoff et al., 2009).
Ethical permission for the study was obtained through the brain
banks from which the tissue was obtained. The entire study was also
reviewed by our local ethics board.
Fig. 2.Representative gel images formitochondrial/cytoplasmic Hb ratios - normalised to beta actin, were determined byWestern blotting. COXIV antibodywas utilised for quality control
of mitochondrial versus cytoplasmic fractions. To summarise data, samples were grouped into age ranges (1 $_amp_$lt; 70, 2 70–79, 3 ≥ 80) and separated by sex and diagnosis type
(control, late PD: late stage disease diagnosed over the age of 60, early PD: early stage disease diagnosed over the age of 60, young PD: early onset disease diagnosed under the age of
60). Values were visualised as boxplots. Boxplots show the median (line), interquartile range (box) and whiskers extend to 1.5× the Inter quartile range. Extreme values beyond the
whiskers are shown as circles. Ctx – Cortex, Cer – Cerebellum, SN – Substantia nigra. C M - cytoplasmic and mitochondrial fractions extracted from the same sample. Mito/cyto – ratio
of mitochondrial Hb compared with cytoplasmic Hb. F-female, M – male. Full densitometry dataset is provided in Supplementary Table 2.
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Mitochondria were prepared as previously described (Shephard
et al., 2013). The quality of the crude fractions was conﬁrmed using
standard Western blotting techniques with nuclear, mitochondrial and
cytoplasmic markers (Histone H3, ab 1791 (Abcam); COX IV ab16056
(Abcam); and HSP-90 ab13495 (Abcam) respectively). Sub-fractions
were conﬁrmed using outer membrane, inner membrane and inter-
membrane space markers.
2.3. Immunoblotting
Western blotting was conducted as previously described (Shephard
et al., 2013). Primary antibodies used were: Hba sc-21005 (Santa Cruz)
1:1000; and ab102758 (Abcam) 1:500 – for ﬂy hypoxia; Hbb sc-22718
(Santa Cruz) 1:1000; COXIV ab16056 (Abcam) 1:1000; beta-actin
ab8227 (Abcam) 1:4000; HSP-90 ab13495 (Abcam) 1:500; VDAC/
Porin ab15895 (Abcam) 1:2000; NDUFS3 ab110246 (Abcam) 1:1000;
SMAC/Diablo ab8115 (Abcam) 1:1000; dilution in 3% (w/v) BSA in
TBS-T. Band densities were measured using Image J and samples were
normalised to beta-actin. Using the normalised values the ratio of mito-
chondrial/cytoplasmic HbA and HbB were calculated. Data were
analysed using the R statistical package http://www.r-project.org/ see
supplemental data for script used to generate Fig. 3.
2.4. Hypoxic treatment
Drosophila melanogaster were maintained using standard tech-
niques. Mixed populations of approx. 100wild type ﬂies were subjectedto the following hypoxic conditions: 2.5% O2 30 min 25 °C followed by
normoxia 30 min 25 °C or 2.5% O2 30 min 25 °C followed by normoxia
30 min 25 °C × 2. Mitochondria were isolated as described above and
subjected to immunoblotting.
2.4.1. Immunohistochemistry
Immunohistochemistry was performed as previously described
(Shephard et al., 2013). Slides were visualised using a Pannoramic
P250 scanner (3D Histech) with Lumencor Spectra Light Engine illu-
mination source. Images were captured using a PCO Edge 5MP
sCMOS monochrome camera and Carl Zeiss Plan ApoChromat 20x/
0.8NA lens. The ﬁlter conﬁguration used is shown in Supplementary
Table 4.
3. Results
3.1. Mitochondrial HbAmigrates from the intermembrane space to the out-
er membrane in affected male cerebellum
Sub-mitochondrial fractions were prepared from cerebella and in-
terrogated for HbA content (Fig. 1A). Fractions were veriﬁed using ap-
propriate antibodies SMAC and NDUFS3 for intermembrane space and
inner membrane respectively. Control (male 80 years) and affected
(male, 82 years, 18 years of disease) cerebella mitochondria were pre-
pared and subfractionated. A female (85 years old, 18 years of disease)
sub-fractionated sample is included for comparison. HbA content of
the fractions was determined by western blotting. We found HbA to
be present in the inter membrane space of the control sample which
corroborates earlier ﬁndings (Shephard et al., 2013). In the affected
sample there is little evidence of HbA in the inter membrane space.
Fig. 3. Scatterplots of mitochondrial/cytoplasmic Hb ratio versus disease duration in years. Scatterplots of the ratio of mitochondrial/cytoplasmic heamoglobin A and B in three tissues.
Patient samples are split by sex and a linear model used to ﬁt a trendline. The shaded areas show the 95% conﬁdence limits of the ﬁtted line. Calculations and plotting was conducted
using ggplot in R (see supplemental R script which was used for generating ﬁgures). Orange circles (female), blue circles (male). Yr – years. Ctx – Cortex, Cer – Cerebellum, SN –
Substantia nigra. (For interpretation of the references to colour in this ﬁgure legend, the reader is referred to the web version of this article.)
Fig. 4. The cellular distribution of HbB appears changed in female cerebellum with disease duration. HbB and COXIV antibodies were utilised to visualise the physical location of
mitochondria and HbB in the cerebellum of female individuals with different disease durations. It appears that with longer disease duration the overall quantity of COXIV is reduced
and the location of HbB shifts in the longest disease course from in and around Purkinje cells observed in controls, to the granule cell layer in sections from 18 years disease duration.
DAPI is used to stain nuclei. Filter sets used are detailed in the methodology.
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Though the amount of HbAwas not absolutely quantiﬁed, relative ratios
suggest that there is a substantial quantity of this protein in or associat-
ed with the outer membrane of the affected sample mitochondria.
3.2. Hb levels increase in Drosophila mitochondrial fractions in response to
cyclical hypoxia
In order to demonstrate an in vivo response of haemoglobin regula-
tion in mitochondria we exposed fruit ﬂies to cycles of hypoxia. Flies
were in the group normoxic if they were not exposed to any hypoxic
events. We tested two groups where the ﬂies were exposed to two or
three cycles of hypoxia (30 min at 2.5% oxygen), each followed by a
recovery period (30 min) in normoxia. Mitochondria were prepared
from whole ﬂies in each of the three groups and Hb content
ascertained in both cytoplasmic and mitochondrial fractions
(Fig. 1B, Supplementary 1). The ratios of Hb content were plotted
to reveal a signiﬁcant increase (p b 0.05) in mitochondrial samples
undergoing three rounds of hypoxia. Samples undergoing two
rounds of hypoxia ﬁtted with a trend towards increased mitochon-
drial Hb with hypoxia.
3.3. Mitochondrial versus cytoplasmic HbA and HbB ratios in early onset,
early stage and late stage Parkinson's
Data for calculating alpha and beta globin ratios were collected by
western blot. Fractionated cell extracts were produced and run to give
cytoplasmic versus mitochondrial ratios (Fig. 2). Ratios were calculated
with reference to beta actin levels in the same lane. COXIV antibody in-
dicated enrichment of mitochondrial fractions. Cortex, cerebellum and
substantia nigra regions of the brain were examined for each sample.
Using the arbitrary grouping of early Parkinson's (within 10 years of
onset), late Parkinson's (beyond 10 years of disease) and young
Parkinson's (onset before 60 years) we were unable to detect any
major differences in mitochondrial/cytoplasmic ratios.
3.4. Mitochondrial haemoglobin ratios exhibit a dynamic range with dis-
ease duration
We re-examined our data set of mitochondrial/cytoplasmic ratios of
alpha and beta haemoglobin, this time against disease duration. Speciﬁc
immunoblotting of HbA and HbB were veriﬁed by LC-MSMS of trypsin
digested proteins from immunopositive and negative gel bands (data
provided in Supplementary Fig. 2). Scatter plots were generated from
the whole set of immunoblotting data and show highly variable rela-
tionships as one might expect from post-mortem unrelated human
brains with a sporadic disease (Fig. 3). However, two regions of the
brain describe a trend towards a change when mitochondrial
haemoglobin is measured. In the cortex, the gender speciﬁc scatter
plots can be summarised by lines demonstrating an increase in mito-
chondrial HbA as the disease duration increases, this is most marked
in the female brain tissues examined (red line). In the cerebellummito-
chondrial HbB shows little dynamic change in mitochondrial HbB in
male samples (blue line). The cerebellumwas subsequently interrogat-
ed more carefully by sub-fractionation of the mitochondrial sample
(Fig. 1A). In female samples mitochondrial HbB trends towards a de-
crease with disease duration going from a ratio of up to 1.5 at 10 years
duration and then decreasing to a ratio ~0.3 by 30 years of disease
course. Interestingly mitochondrial HbB ratio in substantia nigra indi-
cates mostly low levels of this protein. This may reﬂect the proportion
of neuron loss in this area of the brain and suggest that the losses in
this area occur early in the disease process.
In order to account for any protein changes with regard to post
mortem interval (PMI) we plotted HbB levels and also themitochondri-
al marker COXIV against the delay after death in hours (Supplementary
Figs. 3 and 4). These conﬁrm that the levels of HbB we see againstdisease duration is not an effect of tissue changes after death has oc-
curred. Brain banks usually have fewer female Parkinson's disease
brains in their collections. We have analysed the full dataset we obtain-
ed but in order to be sure that differences in the numbers of females and
males analysed did not skew our dataset we disease stage and age
matched each female Parkinson's brain mitochondrial fraction (n = 7)
with a male brain (n = 7) mitochondrial fraction and re-ran the data
to show the gender difference is upheld with equal numbers of samples
from each gender (Supplementary Fig. 6). Multiple linear regression
analysis (software Genstat) was performed to verify that PMI is not a
confounding factor in our analyses with disease duration – Supplemen-
tary Table 3.
3.5. The cellular distribution of HbB changes in female cerebellum with dis-
ease duration
Using antibodies to HbB and COXIV (for mitochondria) we localised
mitochondrial haemoglobin in the female cerebellum (Fig. 4). In the fe-
male control cerebellum large Purkinje cells are labelledwith both anti-
bodies demonstrating the presence of mitochondrial HbB in the cell
body. The cerebellum examined from a female patient 9 years into the
disease suggests an overall decrease of mitochondrial HbB and mito-
chondria too. The patient shown with disease duration of 18 years ap-
pears to show COXIV staining in a different pattern again through the
cerebellum, moving away from the Purkinje cell layer. HbB staining is
increasingly distant from the Purkinje cell layer region of the cerebel-
lum. Purkinje cell staining is relatively reduced. The brightness of the
COXIV stain appears decreased in both affected brains. All the images
presented were stained and imaged in a single batch to ensure valid
qualitative comparison between images. The changes appear to be re-
lated to HbB protein localisation and this is something that needs to
be looked into further.
4. Discussion
Our observations on the dynamic location of Hb led us to ask what
could be the drivers of this proteins mobility within the cell and its or-
ganelles (Shephard et al., 2013). An obvious place to start is the manip-
ulation of oxygen saturation and or delivery as has been donepreviously
in vitro (Grek et al., 2011). We devised an experimental regime where
we subject Drosophila to hypoxia. In order to emulate longer term ﬂuc-
tuations in oxygen availability we exposed ﬂies to single or double hyp-
oxic events, each followed by an equal period of recovery. Examination
of mitochondrial fractions isolated from the ﬂies revealed a signiﬁcant
increased ratio of mitochondrial Hb in response to multiple cycles of
hypoxia and recovery. We suggest that this is indicative of a possible
protective mechanismwhereby Hb is sequestered to the mitochondrial
organelle in conditions of hypoxia, perhaps in order to maintain an es-
sential oxygen supply to the organelle. In long-lived brains this could
occur in response to age related vascular changes when suboptimal
quantities of oxygenated blood could be delivered to this most impor-
tant organ (Qiu and Fratiglioni, 2015). It is possible that this is present
at some level in multiple sclerosis where it is shown that HbB is found
at higher levels in cortical neurons (Broadwater et al., 1812). However
over a lifetime, unregulated sequestering of Hb in the organelle could
lead to toxic levels within the intermembrane space. At the tipping
point, overloaded organelles might be targeted for removal by
mitophagy (Chakrabarti et al., 2009). In order to examine the
localisation of Hb in human brains we carefully examinedmitochondri-
al haemoglobin levels in control and age matched Parkinson's disease
mitochondria.
We show that the levels of mitochondrial Hb trend towards a de-
crease in the cerebellum of females with Parkinson's. In males we ﬁnd
that the Hb content of the mitochondria does not appear decreased
overall, sub-mitochondrial fractionation reveals that the Hb content
though maintained, has moved into a different mitochondrial
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does not allow us to specify whether Hb is merely associated with the
external surface of the organelle or contained within the membrane or-
ganelle. Importantly, in males Hb is no longer detected in the inter
membrane space where it is found in controls and in affected female
cerebellum, this takes it away from the site of Complex 1 activity
where it is shown to have an effect (Brunyanszki et al., 2015). Our sam-
ple set for this study is small, in particular there is some difﬁculty in
obtaining large sample sets of female brains since the disease is less fre-
quently encountered by women (Caslake et al., 2013). We would be in-
terested to see whether other groups with similar or larger size sample
sets can replicate these ﬁndings. Gender differences in Parkinson's dis-
ease arewell documented, with females having a lower risk and a trem-
or dominant phenotype as well as reduced motor symptoms (Caslake
et al., 2013). The cause of this is currently unknown but could be impor-
tant in terms of generating neuroprotective therapies exploiting gender
speciﬁc mechanisms. Our ﬁnding that mitochondrial Hb may be modu-
lated differently according to gender could be a result of gender speciﬁc
systemic availability of oxygen. Females in their reproductive years are
particularly prone to anaemia (Pasricha et al., 2014). A recent article
now connects haptoglobin a haemoglobin binding protein with low
levels of serum iron, also with a greater effect when stratifying by gen-
der (Costa-Mallen et al., 2015). There is gathering evidence that iron
levels and anaemia are likely to be important players in the area of neu-
rodegeneration, it is interesting to note that it is still unknown where
the iron accumulation, seen for example in Parkinson's, originates
Hametner et al., 2013; Mochizuki and Yasuda, 2012.
This study is important in identifying molecular changes in the cer-
ebellum of PD post mortem brain. Recently the cerebellum has piqued
the interest of PD researchers and has been postulated as a potential
source of compensatory signalling (Lewis et al., 2013; Wu and Hallett,
2013; Rodríguez-Cueto et al., 2014). Change in glucose metabolism
has been found to be an early event in the PD cerebellum and there
have been a number of imaging studies that implicate the importance
of this part of the brain in PD (Dunn et al., 2014). Our discovery of gen-
der relatedmolecular changes in PDmitochondria is an essential step in
understanding the observed differences in symptomology between
males and females with PD (Caslake et al., 2013; Colombo et al., 2015;
Caranci et al., 2013; Solla et al., 2012; Cereda et al., 2014). As we are
able to deﬁne the gender effect, common pathways can be better de-
ﬁned and compensatory loops, such as those proposed involving the
cerebellum, can be targeted for therapy (Wu and Hallett, 2013).
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.mito.2016.05.001.Ethics
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